A carregar...
Novel agents in the treatment of Hodgkin lymphoma: Biological basis and clinical results
Hodgkin Lymphoma (HL) is a lymphoproliferative disorder of B cells that commonly has a favorable prognosis when treated with either combination chemotherapy and radiation therapy, or chemotherapy alone. However, the prognosis for patients who relapse, or have evidence for refractory disease, is poor...
Na minha lista:
| Publicado no: | Semin Hematol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5572135/ https://ncbi.nlm.nih.gov/pubmed/27496310 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminhematol.2016.05.011 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|